<DOC>
	<DOC>NCT00765024</DOC>
	<brief_summary>A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.</brief_summary>
	<brief_title>Ivermectin Versus Albendazole for Chronic Strongyloidiasis</brief_title>
	<detailed_description />
	<mesh_term>Strongyloidiasis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Patients with positive strongyloides larva in the stool Pregnancy Lactating women Known allergy to any study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>strongyloidiasis, ivermectin, albendazole</keyword>
</DOC>